monoclonal antibody muj591
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 1998 (NCT00003391)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate carboxypeptidase IIINHIBITOR
FOLH1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- monoclonal antibody muj591
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00006380 | Phase 1 | Sep 1, 2000 | Cornell University, National Cancer Institute (NCI) |
| NCT00003391 | Phase 1 | Jun 1, 1998 | Cornell University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 2 | 2 | 1 | 1998 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2000 |
2 organizations
Page 1 / 1